Search Results - "Villanueva Silva, Maria Jose"

An analysis of prognostic factors in a cohort of low-grade gliomas and degree of consistency between RTOG and EORTC scores by Pérez, Isaura Fernández, Valverde, Diana, Valverde, Concepción Fiaño, Iglesias, Jenifer Brea, Silva, María José Villanueva, Quintela, Martín Lázaro, Meléndez, Bárbara

“…Due to their rarity and heterogeneity and despite the introduction of molecular features in the current WHO classification, clinical criteria such as those…”
Get full text

Results of phase II randomized study of intermittent versus continuous schedule of vemurafenib plus cobimetinib in BRAF-mutated advanced melanoma by Gonzalez-Cao, Maria, Mayo de las Casas, Clara, Oramas, Juana, Berciano-Guerrero, Miguel-Angel, De la Cruz, Luis, Cerezuela-Fuentes, Pablo, Arance, Ana Maria, Muñoz-Couselo, Eva, Espinosa, Enrique, Puértolas, Teresa, Diaz Beveridge, Robert, Ochenduszko, Sebastian, Villanueva Silva, Maria Jose, Basterretxea, Laura, Bellido, Lorena, Rodriguez-Abreu, Delvys, Drozdowskyj, Ana, Molina Vila, Miguel Angel, Lopez-Martin, Jose Antonio, Berrocal, Alfonso

“…Abstract only 9528 Background: Combination of vemurafenib plus cobimetinib is approved for the treatment of BRAF-mutated advanced melanoma. Although patients…”
Get full text

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients by Gligorov, J, Ataseven, B, Verrill, M, De Laurentiis, M, Jung, K.H, Azim, H.A, Al-Sakaff, N, Lauer, S, Shing, M, Pivot, X

“…Abstract Aim To assess the safety and tolerability of adjuvant subcutaneous trastuzumab (Herceptin® SC, H SC), delivered from an H SC Vial via hand-held…”
Get full text

A phase II/III randomized double-blind study of octreotide acetate LAR with axitinib versus octreotide acetate LAR with placebo in patients with advanced G1-G2 NETs of non-pancreatic origin (AXINET trial-GETNE-1107) by Garcia-Carbonero, Rocio, Benavent, Marta, Jiménez Fonseca, Paula, Castellano, Daniel, Alonso, Teresa, Teule, Alex, Custodio, Ana, Tafuto, Salvatore, La Casta Munoa, Adelaida, Spada, Francesca, López-López, Carlos, Ibrahim, Toni, Villanueva Silva, Maria Jose, Iranzo, Vega, Garcia-Alfonso, Pilar, González, Encarnación, Grande, Enrique, Crespo, Guillermo, Capdevila, Jaume

“…Abstract only 360 Background: Angiogenesis plays an important role in NET development and progression. Axitinib is a potent and selective VEGFR-1,2,3…”
Get full text

Analysis of the relationship between ratio N/L and survival in lung cancer patients treated with immunotherapy by De Dios Alvarez, Noemi, Costa Rivas, Marinha, Agraso Busto, Sara, Pereiro Corbacho, Diego, Alonso Herrero, Ana, García Benito, Carmé, Villanueva Silva, Maria Jose, Huidobro Vence, Gerardo, Lázaro Quintela, Martín Emilio, Castellanos Diez, Javier, Casal Rubio, Joaquín

“…Abstract only e14247 Background: The neutrophil-lymphocyte (N / L) ratio is a marker of general immune response in different stress situations, having shown a…”
Get full text

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cáncer (NS-NSCLC). A Galician Lung Cancer Group Study by Areses Manrique, Mª Carmen, Fernández Núñez, Natalia, Covela Rúa, Marta, Alonso Herrero, Ana, Villanueva Silva, Maria Jose, Afonso Afonso, Francisco J., Esquerdo, Gaspar, Campos Balea, Begoña, Lázaro Quintela, Martin, Garcia Mata, Jesus, Vazquez-Estevez, Sergio, Anido Herranz, Urbano, Casal Rubio, Joaquin, Firvida Perez, Jose Luis

“…Abstract only…”
Get full text

Utility of Genomic Platforms in Treatment Decisions in Axilla-Positive Breast Cancer by Fernández Pérez, Isaura, Tuñas, Lidia Vázquez, Corbacho, Diego Pereiro, Benito, Carme García, Ojea, Clara González, Fernández, Alberto Garrido, Silva, María José Villanueva, Lorenzo, Isabel Lorenzo, Rubio, Joaquín Casal

Get full text

GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC) by Vazquez Estevez, Sergio, Villanueva Silva, Maria Jose, Firvida Perez, Jose Luis, Lazaro Quintela, Martin, Varela Ferreiro, Silvia, Huidobro Vence, Gerardo, Fernandez Calvo, Ovidio, Campos Balea, Begona, Casal Rubio, Joaquin, Areses Manrique, Carmen

“…Abstract only e18146 Background: Efficacy of oral erlotinib has been conclusively established in 2 nd line setting (BR.21 and TRUST studies) and the outcomes…”
Get full text

Study of the usefulness of angiotensin type 1 receptor (AGTR1) as a possible response predictor in patients with metastatic breast cancer (mBC) subjected to chemotherapy and treatment with bevacizumab (AVALUZ Study) by De la Haba- Rodriguez, Juan, Salvador Bofill, Javier, Codes, Manuel, Ciruelos, Eva M., Jaen, Ana, Galan, Antonio, Gil, Miquel, Serrano, M. Jose, Baena, Jose Manuel, Villanueva Silva, Maria Jose, Gonzalez, Encarnacion, Murias, Adolfo, Miguel, Ana, Garcia, Helena, Bayo, Juan L., Sánchez-Rovira, Pedro

“…Abstract only 10608 Background: Angiotensin type 1 receptor (AGTR1) is a membrane receptor implicated in the regulation of arterial pressure. It has also been…”
Get full text

AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: OS analysis by Salvador, Javier, Ciruelos, Eva M., Codes, Manuel, Jaen, Ana, Gil, Miquel, Galan, Antonio, Murias, Adolfo, Jara-Sanchez, Carlos, De la Haba- Rodriguez, Juan, Baena, Jose Manuel, Villanueva Silva, Maria Jose, Bayo, Juan L., Blancas, Isabel, Gonzalez, Encarnacion, Perez, Diego, Mel, Jose Ramón, Manso, Luis

“…Abstract only e11535 Background: The combination of bevacizumab (B) with taxanes, capecitabine or anthracyclines has shown increased PFS in pts with mBC. The…”
Get full text

Erlotinib as frontline treatment for elderly patients (p) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): GGCP044/09 study by Firvida Perez, Jose Luis, Vazquez Estevez, Sergio, Casal Rubio, Joaquin, Alonso Bermejo, Miguel, Varela Ferreiro, Silvia, Villanueva Silva, Maria Jose, Afonso Afonso, Francisco J., Lazaro Quintela, Martin, Areses Manrique, Carmen, Campos Balea, Begona, Huidobro Vence, Gerardo, Fernandez Calvo, Ovidio, Alvarez Gomez, Elena, Grande Ventura, Carlos, Fernandez Montes, Ana, Castro Gomez, Enrique, Mel Lorenzo, Jose Manuel

“…Abstract only e18040 Background: NSCLC is primarily a disease of older people with a median age of approximately 70 years (y) at diagnosis. Platinum…”
Get full text